MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH…
MaaT PharmaDecember 10, 2024
MaaT Pharma Announces First U.S. Patient Treated at City of Hope Under Single Patient Expanded…
MaaT PharmaDecember 5, 2024
MaaT Pharma Announces Positive Phase 1b Results, Meeting Primary Endpoint in the Evaluation of MaaT033…
MaaT PharmaNovember 26, 2024
MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting…
MaaT PharmaNovember 7, 2024